Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incremental net benefit in randomized clinical trials.

A R Willan1, D Y Lin

  • 1Department of Clinical Epidemiology and Biostatistics, McMaster University and Centre for Evaluation of Medicines, St Joseph's Hospital, 600-143 James Street South, Hamilton, ON, L8P 3A1, Canada. willana@mcmaster.ca

Statistics in Medicine
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Checking the Cox Proportional Hazards Model with Interval-Censored Data.

Journal of the American Statistical Association·2025
Same author

Semiparametric Regression Analysis of Interval-Censored Multi-State Data with An Absorbing State.

Journal of the American Statistical Association·2025
Same author

Multiancestry Genome-Wide Association Study of Early Childhood Caries.

Journal of dental research·2024
Same author

Maximum likelihood estimation for semiparametric regression models with interval-censored multistate data.

Biometrika·2024
Same author

Multi-ancestry Genome-Wide Association Study of Early Childhood Caries.

medRxiv : the preprint server for health sciences·2024
Same author

Marginal proportional hazards models for multivariate interval-censored data.

Biometrika·2023

Health economic evaluations compare therapies using cost minimization, incremental cost-effectiveness, or incremental net benefit. Expressing net benefit in cost units unifies these approaches for analysis, simplifying comparisons.

Area of Science:

  • Health economics
  • Clinical trial analysis
  • Therapeutic comparison

Background:

  • Three primary methods exist for health economic evaluations comparing therapies: cost minimization, incremental cost-effectiveness ratio (ICER), and incremental net benefit (INB).
  • Each method offers a different perspective on the value of one therapy over another.
  • Understanding the relationship between these methods is crucial for robust economic evaluations.

Purpose of the Study:

  • To demonstrate a unified graphical approach for health economic evaluations.
  • To show how expressing incremental net benefit in monetary units facilitates the integration of cost minimization, ICER, and INB.
  • To illustrate the application of this unified approach using clinical trial data.

Main Methods:

Related Experiment Videos

  • The study proposes expressing incremental net benefit in units of cost.
  • This allows for a single graphical representation encompassing cost minimization, ICER, and INB.
  • Standard two-sample statistical procedures are applicable when cost and effectiveness data are not censored.

    • Main Results:

    • A unified graphical method was presented for comparing therapies in health economic evaluations.
    • The approach integrates cost minimization, incremental cost-effectiveness, and incremental net benefit analyses.
    • Statistical inferences for all three approaches can be visualized simultaneously.

    Conclusions:

    • Expressing incremental net benefit in cost units provides a versatile framework for health economic evaluations.
    • This unified approach simplifies the interpretation and comparison of different evaluation methods.
    • The method is applicable to clinical trial data, with or without censoring.